Onconetix, Inc. SEC filings ONCO
Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 7, 2026 | Nov 10, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2026 | Sep 17, 2026 |
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| DEF 14A | Proxy statement | Mar 30, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2026 | Apr 30, 2026 |
| DEF 14A | Proxy statement | Jan 2, 2026 | Feb 3, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 22, 2025 | Dec 22, 2025 |
| DEF 14A | Proxy statement | Nov 10, 2025 | Dec 5, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 29, 2025 | Oct 28, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2025 | May 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| DEF 14C | Information statement | Oct 31, 2024 | Nov 1, 2024 |
| PRE 14C | Preliminary information statement | Oct 18, 2024 | Oct 18, 2024 |
| DEFA14A | Additional proxy material | Sep 3, 2024 | — |
| DEF 14A | Proxy statement | Aug 1, 2024 | Sep 5, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 14, 2024 | Feb 14, 2024 |
| DEF 14A | Proxy statement | Apr 26, 2023 | May 31, 2023 |
| DEF 14A | Proxy statement | Jul 18, 2022 | Aug 22, 2022 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONCO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782107
- Former names
- Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.